Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Hungnes

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 17, 2009
[Disease caused by the new influenza A(H1N1) virus]Siri Helene Hauge, Susanne Gjeruldsen Dudman, Katrine Borgen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2021
Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and SwedenHanne-Dorthe Emborg, AnnaSara Carnahan, Karoline Bragstad, et al.
Plos One|November 18, 2017
Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancyMiloje Savic, Jennifer L Dembinski, Ida Laake, et al.
Vaccine|July 7, 2020
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019Angeliki Melidou, Olav Hungnes, Dmitriy Pereyaslov, et al.
Influenza and Other Respiratory Viruses|January 20, 2020
Detection of anti-NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated casesAnna Hayman Robertson, Milada Mahic, Miloje Savic, et al.
BMC Infectious Diseases|October 24, 2018
Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort studyIda Laake, Gro Tunheim, Anna Hayman Robertson, et al.
Scientific Reports|October 29, 2024
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patientIgnacio Garcia, Jon Bråte, Even Fossum, et al.
Zoonoses and Public Health|March 20, 2026
A Retrospective Cross-Sectional Study (2009-2023): Exploring Influenza A(H1N1)pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target GroupsSolveig Jore, Ragnhild Tønnessen, Carl Andreas Grøntvedt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2021
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021Elina Seppälä, Lamprini Veneti, Jostein Starrfelt, et al.
Diabetologia|June 24, 2018
Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort studyPaz L D Ruiz, German Tapia, Inger J Bakken, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 17, 2009
[Disease caused by the new influenza A(H1N1) virus]Siri Helene Hauge, Susanne Gjeruldsen Dudman, Katrine Borgen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2021
Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and SwedenHanne-Dorthe Emborg, AnnaSara Carnahan, Karoline Bragstad, et al.
Plos One|November 18, 2017
Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancyMiloje Savic, Jennifer L Dembinski, Ida Laake, et al.
Vaccine|July 7, 2020
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019Angeliki Melidou, Olav Hungnes, Dmitriy Pereyaslov, et al.
Influenza and Other Respiratory Viruses|January 20, 2020
Detection of anti-NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated casesAnna Hayman Robertson, Milada Mahic, Miloje Savic, et al.
BMC Infectious Diseases|October 24, 2018
Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort studyIda Laake, Gro Tunheim, Anna Hayman Robertson, et al.
Scientific Reports|October 29, 2024
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patientIgnacio Garcia, Jon Bråte, Even Fossum, et al.
Zoonoses and Public Health|March 20, 2026
A Retrospective Cross-Sectional Study (2009-2023): Exploring Influenza A(H1N1)pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target GroupsSolveig Jore, Ragnhild Tønnessen, Carl Andreas Grøntvedt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2021
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021Elina Seppälä, Lamprini Veneti, Jostein Starrfelt, et al.
Diabetologia|June 24, 2018
Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort studyPaz L D Ruiz, German Tapia, Inger J Bakken, et al.
Pageof 8